These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 9094149)

  • 1. Regional differences in the effects of amphetamine withdrawal on dopamine dynamics in the striatum.
    Lee TH; Ellinwood EH; King GR
    Neuropsychopharmacology; 1997 Apr; 16(4):311-4. PubMed ID: 9094149
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopamine partial agonist reverses amphetamine withdrawal in rats.
    Orsini C; Koob GF; Pulvirenti L
    Neuropsychopharmacology; 2001 Nov; 25(5):789-92. PubMed ID: 11682262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Withdrawal from morphine or amphetamine: different effects on dopamine in the ventral-medial striatum studied with microdialysis.
    Crippens D; Robinson TE
    Brain Res; 1994 Jul; 650(1):56-62. PubMed ID: 7953677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amphetamine produces sensitized increases in locomotion and extracellular dopamine preferentially in the nucleus accumbens shell of rats administered repeated cocaine.
    Pierce RC; Kalivas PW
    J Pharmacol Exp Ther; 1995 Nov; 275(2):1019-29. PubMed ID: 7473128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Withdrawal from chronic amphetamine reduces dopamine transmission in the rat lateral septum.
    Renard GM; Sotomayor-Zarate R; Blanco EH; Gysling K
    J Neurosci Res; 2014 Jul; 92(7):937-43. PubMed ID: 24753218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A sensitizing regimen of amphetamine impairs visual attention in the 5-choice serial reaction time test: reversal by a D1 receptor agonist injected into the medial prefrontal cortex.
    Fletcher PJ; Tenn CC; Sinyard J; Rizos Z; Kapur S
    Neuropsychopharmacology; 2007 May; 32(5):1122-32. PubMed ID: 17047670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of withdrawal from an escalating dose of amphetamine on conditioned fear and dopamine response in the medial prefrontal cortex.
    Peleg-Raibstein D; Feldon J
    Behav Brain Res; 2008 Jan; 186(1):12-22. PubMed ID: 17884189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cocaine withdrawal and the cerebral influx of [18F]fluoro-L-DOPA (FDOPA).
    Cumming P; Reith J; Gjedde A
    Neuropsychopharmacology; 1999 Apr; 20(4):395-8. PubMed ID: 10088142
    [No Abstract]   [Full Text] [Related]  

  • 9. Serotonin dysfunction in the nucleus accumbens of rats during withdrawal after unlimited access to intravenous cocaine.
    Parsons LH; Koob GF; Weiss F
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1182-91. PubMed ID: 7562486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spatial and temporal profile of haloperidol-induced immediate-early gene expression and phosphoCREB binding in the dorsal and ventral striatum of amphetamine-sensitized rats.
    Hsieh HC; Li HY; Lin MY; Chiou YF; Lin SY; Wong CH; Chen JC
    Synapse; 2002 Sep; 45(4):230-44. PubMed ID: 12125044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Striatal acetylcholine release correlates with behavioral sensitization in rats withdrawn from chronic amphetamine.
    Bickerdike MJ; Abercrombie ED
    J Pharmacol Exp Ther; 1997 Aug; 282(2):818-26. PubMed ID: 9262346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of short-term abstinence from escalating doses of D-amphetamine on drug and sucrose-evoked dopamine efflux in the rat nucleus accumbens.
    Vacca G; Ahn S; Phillips AG
    Neuropsychopharmacology; 2007 Apr; 32(4):932-9. PubMed ID: 16885936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitization of locus ceruleus neurons during withdrawal from chronic stimulants and antidepressants.
    Harris GC; Williams JT
    J Pharmacol Exp Ther; 1992 May; 261(2):476-83. PubMed ID: 1578363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the role of striatal and nonstriatal dopamine in opiate withdrawal.
    Herz A; Bläsig J; Laschka E; Gramsch C
    Adv Biochem Psychopharmacol; 1977; 16():597-9. PubMed ID: 560794
    [No Abstract]   [Full Text] [Related]  

  • 15. [Significance of catecholamines for the manifestation of morphine withdrawal in the rat].
    Bläsig J; Papeschi R; Herz A
    Arzneimittelforschung; 1974 Jul; 24(7):1015-6. PubMed ID: 4408108
    [No Abstract]   [Full Text] [Related]  

  • 16. Expression of amphetamine-induced behavioral sensitization after short- and long-term withdrawal periods: participation of mu- and delta-opioid receptors.
    Magendzo K; Bustos G
    Neuropsychopharmacology; 2003 Mar; 28(3):468-77. PubMed ID: 12629526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amineptine in the treatment of amphetamine withdrawal: a placebo-controlled, randomised, double-blind study.
    Jittiwutikan J; Srisurapanont M; Jarusuraisin N
    J Med Assoc Thai; 1997 Sep; 80(9):587-92. PubMed ID: 9347672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alcohol-withdrawn animals have a prolonged increase in dopamine D2high receptors, reversed by general anesthesia: relation to relapse?
    Seeman P; Tallerico T; Ko F
    Synapse; 2004 May; 52(2):77-83. PubMed ID: 15034913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of prodynophin, c-fos, and serotonin transporter mRNA following withdrawal from a chronic, escalating dose regimen of D-amphetamine.
    Horner KA; Noble ES; Lauterbach EC
    Synapse; 2009 Apr; 63(4):257-68. PubMed ID: 19116947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amphetamine-induced locomotion, behavioral sensitization to amphetamine, and striatal D2 receptor function in rats with high or low spontaneous exploratory activity: differences in the role of locus coeruleus.
    Alttoa A; Eller M; Herm L; Rinken A; Harro J
    Brain Res; 2007 Feb; 1131(1):138-48. PubMed ID: 17156751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.